Deutsche Bank Aktiengesellschaft began coverage on shares of Astera Labs (NASDAQ:ALAB – Free Report) in a research note published on Monday morning, MarketBeat Ratings reports. The firm issued a buy rating and a $85.00 price objective on the stock.
Other analysts have also issued research reports about the stock. Northland Securities started coverage on shares of Astera Labs in a research report on Monday, March 25th. They issued an outperform rating and a $85.00 target price on the stock. Barclays started coverage on Astera Labs in a report on Monday. They issued an overweight rating and a $85.00 price objective on the stock. Stifel Nicolaus started coverage on Astera Labs in a report on Monday. They set a buy rating and a $81.00 target price for the company. Morgan Stanley began coverage on Astera Labs in a research note on Monday. They issued an overweight rating and a $81.00 price target on the stock. Finally, Roth Mkm initiated coverage on Astera Labs in a research note on Monday. They issued a buy rating and a $85.00 price objective for the company. Eleven investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company presently has a consensus rating of Buy and an average price target of $86.09.
Check Out Our Latest Stock Report on Astera Labs
Astera Labs Price Performance
Insiders Place Their Bets
In related news, Director Jack R. Lazar bought 10,000 shares of the business’s stock in a transaction on Friday, March 22nd. The stock was acquired at an average cost of $36.00 per share, with a total value of $360,000.00. Following the purchase, the director now directly owns 165,000 shares of the company’s stock, valued at $5,940,000. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.
Institutional Investors Weigh In On Astera Labs
A hedge fund recently bought a new stake in Astera Labs stock. Allspring Global Investments Holdings LLC acquired a new position in Astera Labs, Inc. (NASDAQ:ALAB – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 251,596 shares of the company’s stock, valued at approximately $18,666,000. Allspring Global Investments Holdings LLC owned 0.16% of Astera Labs as of its most recent filing with the Securities & Exchange Commission.
Astera Labs Company Profile
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
See Also
- Five stocks we like better than Astera Labs
- The Role Economic Reports Play in a Successful Investment Strategy
- Comprehensive PepsiCo Stock Analysis
- 3 Grocery Stocks That Are Proving They Are Still Essential
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- Short Selling: How to Short a Stock
- Bear Market Funds to Watch This Year
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.